文献速递主动脉疾病

现成内分支胸腹主动脉覆膜支架用于治疗近肾及肾旁腹主动脉瘤

Use of an Off the Shelf Inner Branch Thoraco-abdominal Endograft for the Treatment of Juxtarenal and Pararenal Aortic Aneurysms.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2025-02-21

多中心前瞻性登记研究纳入185例连续接受E-nside现成预载内分支覆膜支架治疗的患者,其中47例(25.4%)为近肾或肾旁腹主动脉瘤。技术成功率100%,30天死亡率为4%,30天主要不良事件累积发生率为26%,1年靶血管不稳定免除率为97±3%。作者认为该支架在急诊和择期环境中可行,卒中和脊髓缺血可能与入路及支架设计带来的主动脉覆盖增加相关。

要点

  • 47例近肾或肾旁腹主动脉瘤患者接受E-nside现成内分支覆膜支架治疗,共纳入183根靶血管。
  • 技术成功率100%,30天死亡率为4%(2例急诊病例),30天主要不良事件累积发生率为26%。
  • 1年靶血管不稳定免除率为97±3%,作者认为卒中和脊髓缺血可能与入路及主动脉覆盖增加相关。

核心结论

  • 使用现成内分支覆膜支架治疗近肾或肾旁腹主动脉瘤在急诊和择期环境中均可行,技术成功率高,1年靶血管稳定性令人满意。
  • 作者认为在近肾或肾旁腹主动脉瘤治疗中,卒中和脊髓缺血可能与手臂入路及该设计带来的主动脉覆盖增加相关。

研究设计与样本

  • 多中心登记研究(INBREED),前瞻性收集并分析接受E-nside覆膜支架治疗的患者数据。
  • 纳入近肾或肾旁腹主动脉瘤患者,记录术前临床和解剖特征、手术数据及30天和1年结局。
  • 185例连续治疗患者中47例(25.4%)为近肾或肾旁腹主动脉瘤(近肾10例,21%;肾旁37例,79%),共纳入183根靶血管。

主要发现

  • 手术背景为急诊或紧急的患者18例(38%),原因包括包裹性主动脉破裂2例(4%)、有症状动脉瘤4例(9%)、动脉瘤>70 mm 12例(26%)。
  • 腹腔干以上主动脉覆盖平均长度为116±7 mm。
  • 技术成功率为100%,30天死亡率为4%(n=2,均为急诊病例)。
  • 30天主要不良事件累积发生率为26%(n=12):卒中2例(4%);脊髓缺血7例(15%),其中择期6例(21%)、急诊1例(6%),5例导致永久性截瘫或轻截瘫(10%)。
  • 靶血管不稳定免除率30天后为99%,1年后为97±3%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate outcomes of an off the shelf pre-loaded inner branched endograft (E-nside) for the treatment of juxtarenal and pararenal abdominal aortic aneurysms (JP-AAAs). METHODS: Data from a multicentre registry (INBREED), including patients treated with the E-nside endograft, were collected and analysed prospectively. Patients treated for JP-AAA were included. Pre-operative clinical and anatomical characteristics, procedural data, and 30 day and one year outcomes were recorded. Endpoints were technical success, 30 day death, major adverse events (MAEs), and one year freedom from target vessel instability. RESULTS: Of 185 consecutively treated patients, 47 (25.4%) had a JP-AAA (juxtarenal n = 10, 21%; pararenal n = 37, 79%) and were included in the study; 183 target vessels were incorporated through an inner branch. Procedural setting was emergency or urgent in 18 patients (38%) owing to a contained aortic rupture (n = 2, 4%), symptomatic aneurysm (n = 4, 9%), or aneurysm > 70 mm (n = 12, 26%). The mean length of aortic coverage above the coeliac trunk was 116 ± 7 mm. Technical success was 100% and 30 day mortality rate 4% (n = 2 urgent cases). The 30 day cumulative MAE rate was 26% (n = 12): two stroke (4%); and seven spinal cord ischaemia (15%), with six in an elective setting (21%) and one in an urgent setting (6%), and five leading to permanent paraplegia or paraparesis (10%). Freedom from target vessel instability was 99% after 30 days and 97 ± 3% after one year. CONCLUSION: Use of an off the shelf inner branched device for treating JP-AAA was feasible in urgent and elective settings, with high technical success and satisfactory target vessel stability at one year. In the treatment of JP-AAA, stroke and spinal cord ischaemia may be associated with arm access and the increased aortic coverage that the design brings.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Squizzato F, Piazza M, Isernia G, et al. Use of an Off the Shelf Inner Branch Thoraco-abdominal Endograft for the Treatment of Juxtarenal and Pararenal Aortic Aneurysms. Eur J Vasc Endovasc Surg. 2025. PMID: 39988241. doi:10.1016/j.ejvs.2025.02.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。